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Renin release following renal artery constriction Involvement of
protein synthesis. J. Atkinson, P. LOthi, and N. Boillat. Institut de
Pharmacologie de 1' flniversité, Lausanne, Switzerland. Unilateral re-
nal artery constriction (solid silver clip, I.D. 0.2 mm) in the uninephrec-
tomized female rat produces renin release as defined by an increase in
plasma renin level (PRL) and a fall in renin cortex renin level (RCRL).
We have investigated whether such renin release is from preformed
renin stores, is dependent on de novo protein synthesis, or involves a
combination of both. We administered the protein synthesis inhibitor,
cyclohexamide (4mg kg' ) or 0.15 MNaCI solvent i.p. 30 mm before
renal artery clipping. Clipping was carried out under brief ether
anesthesia. Blood samples were taken from a polyethylene intra-aortic
cannula implanted at the same time as uninephrectomy was carried out,
that is, 24 hr prior to clipping. Samples were taken before the intraperi-
toneal injection and at 45 mm after clipping or sham clipping. The
clipped or sham clipped kidney was removed at the end of the
experiment. Renin levels were determined by incubation with an excess
of rat substrate and radioimmunoas say for determination of angiotensin
I. Protein content was measured by the Peterson modification of
the Lowry method. PRL and RCRL are expressed as ngAI mg(protein)' hr'.
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Following clipping in both control and cyclohexamide pretreated rats,
there was a fall in renin specific activity. The increase in the renin
activity of the plasma in cyclohexamide pretreated rats was, however,
approximately half that observed in control, clipped rats. The results
suggest that the increase in PRL following clipping is from both
preformed stores and de novo synthesis.
Prazosin-induced renin release is blocked by propranolol. J. Atkinson,
P. LOthi, and N. Boillat. Institut de Pharmacologie de I' Université,
Lausanne, Switzerland. It is unclear whether the fall in blood pressure
produced by the alpha-I adrenoceptor antagonist, prazosin, is or is not
accompanied by renin release. We have investigated this phenomenon
in the conscious female rat. Animals were chronically implanted with
intra-aortic polyethylene cannula. They were injected with 0, 0.1, 0.3,
or 1 mg prazosin kg s.c., combined with 0, 1, or 3 mg dl propran-
olol kg. Mean arterial blood pressure (MAP, mm Hg) and heart rate
(HR, bpm) were measured continuously for the next 3.5 hr. Blood
samples for plasma renin level determination (PRL, ng Al
ml hr) were taken at 30, 75, 120, and 210 mm after the injection.
The two higher doses of prazosin produced a fall in MAP [0.3 mg kg",
starting value(SV) 106 2mm Hg, A —15 2%, 1 mg kg", SV 106
4, A —10 3%] and an increase in HR (0.3mg. kg, SV 357 28 bpm,
A +15 5%, 1 mg kg"", SV 349 13, A +21 6%). Neither
parameter significantly changed after 0.1 mg prazosin kg"'. All three
prazosin doses produced increases in PRL (0.1 mg kg', SV 16 5
ngAU mi"' hr"', A +119 11%, 0.3mg• kg', SV 14 4, A +230
44%, 1 mg kg"", SV 13 2, A +301 96%). Thus, all doses of
prazosin, even a low dose which did not lower MAP, induced renin
release. Concomitant administration of propranolol, a beta-adrenocep-
tor antagonist, accentuated the prazosin-induced fall in MAP, reversed
the tachycardia, and markedly attenuated the increase in PRL. We
conclude that following single injections of the antihypertensive agent,
prazosin, there is an increase in PRL in the rat. This renin release is
possibly mediated by a prazosin-induced increase in circulating
catecholamines.
Progression of 1gM-associated mesangial proliferative glomerulone-
phritis to focal and segmental hyalinosis. J. Aubert, A. de Torrenté, L.
Humair, and F. Chdtelanat. Hôpital Communal La Chaux-de-Fonds,
Institut de Pathologie, Genéve, Switzerland. Various glomerular le-
sions may cause the nephrotic syndrome: membranous glomerulone-
phritis, minimal change disease (MCD), focal and segmental glonierulo-
sclerosis and hyalinosis, and 1gM proliferative mesangial glomerulone-
phritis (M5PGN), a new clinico-pathological entity recently described.
The question rises whether minimal change disease, MsPGN, and focal
and segmental hyalinosis are not part of a spectrum of a single
pathogenic process. We report the case of a 72-year-old man with no
previous history of kidney disease or hypertension until the end of
January 1981. At that time, he visited his physician because of a sore
throat. A nephrotic syndrome was diagnosed with heavy proteinuria
(9.5 glday) without hematuria. ASLO titer was normal; plasma creati-
nine was 154 fLmoles/liter; ANA were negative and complement studies
normal. A renal biopsy performed in March 1981 showed an increase in
the mesangial cell and matrix; immunofluorescence studies revealed
focal mesangial 1gM, C3, and Clq deposition. Our patient showed first
excellent corticosensitivity and later corticodependence and in part
corticoresistance. A second biopsy was done in December 1981: The
glomeruli still showed some degree of mesangial proliferation but
principally the appearance of focal and segmental hyalinosis. Immuno-
fluorescence studies showed rare 1gM deposition and no C3. This is the
first report, to our knowledge, with immunofluorescence studies of 1gM
mesangial nephropathy which later progressed to focal glomerulo-
sclerosis with 1gM deposition. This evolution seems to confirm the
hypothesis that 1gM MsPGN and focal glomerulosclerosis represent
opposite ends of the spectrum of a single disease. As shown in clinical
and experimental studies, lesions of focal glomerulosclerosis seem to be
rather the complication than the cause of the nephrotic syndrome. It
will be important to know if the presence of 1gM deposition in the
glomeruli of nephrotic patients with MCD or MsPGN indicate a
relatively poor prognosis with potential evolution to focal glomerulo-
sclerosis, corticodependence or resistance, and renal failure.
CAPD System Zurich—Smart, Safe, Simple. U. Binswanger, E.
LOthy, S. Peter, G. Keusch, and G. Bichsel. Nephrologische Station,
Departement für Innere Medizin, Universitdt Zurich, and Grosse
Apotheke Interlaken, Switzerland. A new double-bag CAPD-System
was devised allowing variable dialysate volume to be delivered from a
2-liter plastic bag which is disconnected during dwell time. The follow-
ing dialysis cycle is initiated by connecting a new system with a V-type
connector; the first dialysate movement is outward from the abdomen
into a 3-liter drainage bag; after "internal chemical sterilization" with
chlorhexidin, the dialysate filling phase is initiated as described before.
The new system is very well accepted by patients. The overall
peritonitis rate during the 98 patient-month experience with the new
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system decreased to one episode every 33 patient months. Comparing
"CAPD-beginners," the old versus the new system, the peritonitis rate
is 1:4.5 and 1:10 patient months, respectively, during an observation
period of 50 patient months for each system. Training time for the new
system amounted to an average of 6 days.
Blood pressure in dehydrated rats. M. Burnier, J. Rio//az, and H. R.
Brunner, Département de Médecine, CHUV, Lausanne, Switzerland.
The role of renin, vasopressin, and sympathetic activity in sustaining
blood pressure in the dehydrated state was investigated in normoten-
sive conscious rats. After 48 hr of dehydration, plasma vasopressin
(AVP) was 14.0 1.7 pg/mi (mean SEM) and plasma norepinephrine
(NE) 0.46 0.05 ng/mI. With additional angiotensin-converting enzyme
inhibition (MK 421, 5 mg p.o., twice daily), blood pressure was reduced
by more than 20% (P < 0.001) and both AVP and NE were significantly
higher at 23.4 3.9 pg/mI (P < 0.01) and 0.83 0.07 ng/ml (P < 0.01)
respectively. In rats with or without MK 421 taken together, there was
an inverse correlation between mean blood pressure and AVP (r =
—0.67, P < 0.01) as well as NE (r — 0.82, P < 0.01). The
administration of a specific vasopressin pressor inhibitor (dPVDAVP)
further reduced mean blood pressure of the rats with a blocked renin
system by 16.9 mm Hg which was significantly different (P < 0.001)
from the 6.4 mm Hg reduction of the control group. These results
indicate that following 48 hr of dehydration the renin angiotensin
system participates with the vasopressin secretory mechanism to
sustain blood pressure. They also suggest that following blockade of the
renin system of dehydrated rats, activation of the sympathetic nervous
system contributes to the blood pressure maintenance.
Interstitial fibrosis of renal allografts in urinary tract obstruction.
H, R. Burger, G. Keusch, D. Baum gartner, F. Largiadèr, and U.
Binswanger. Institut für Pathologic, Nephrologische Station und Chir-
urgische K/in/k A des Universitätsspitals Zurich, Zurich, Switzerland.
In IS patients (19 12 years 23 ureteral operations (4 uretrolysis and
splintings of the ureter, 10 reimplantations of ureter, 8 ureteropyelosto-
mies with the patients ureter to the transplanted pelvis) were performed
8.3 7.3 months after kidney transplantation. The indication for the
operation was a radiologically documented dilatation of the renal pelvis
and/or the ureter. The preoperative clinical findings were as follows:
Serum creatinine: 304 179 omoIes/liter, mild hypertension: 11 out of
18 patients, urine volume: 2109 856 ml, proteinuria < 2 g/24 hr: 17 out
of 18 patients, erythrocyturia: 7 out of 18 patients, recurrent urinary
tract infections: 8 out of 18 patients, hemoglobin: 10.5 2.2 g/dl. Six
months after the operation, the kidney function improved in one
patient, deteriorated in seven patients, stabilized in three patients, and
three patients returned to hemodialysis. Twelve months after the
operation the kidney function deteriorated in 2 patients and 2 patients
were stabilized, whereas 6 patients had returned to hemodialysis. In all
patients 35 biopsies were performed. The morphological findings were
as follows: a moderate to severe interstitial fibrosis (especially in the
subcapsular area) in 25 biopsy specimens, a moderate to severe edema
in 16, dilatation of tubuli in 8, and hyaline thrombi in the interstitium in
5. All three patients, who returned to hemodialysis within 3 months
after operation, had a progression of the interstitial fibrosis. Nineteen
biopsy specimens did not exhibit vascular lesions. In two biopsy
specimens a mild acute to subacute vascular rejection and in one a
moderate chronic vascular rejection was observed. In ten specimens
stasis in some capillaries and in four little interstitial hemorrhages were
present. ln conclusion, our histological observations are in accordance
with experimental findings in urinary tract obstruction. It is suggested
that an isolated interstitial fibrosis without any other severe lesions is
suspected of a urinary tract obstruction in the renal aliqgraft. The
missing lymph drainage in the transplanted kidney may be responsible
for these excessive interstitial fibrosis.
Focal segmental glomeruloscierosis in analgesic nephropathy. M. Bbr-
gin, M. Schmidt, and F. Gloor. Institut für Pathologic, Kantonsspital
St. Gal/en, St. Gal/en, Switzerland. In 120 autopsies performed on 83
females and 37 males with analgesic nephropathy (AN), the amount and
distribution of focal segmental glomerular sclerosis/hyalinosis (FSGS/
H) have been investigated. Histological findings were correlated with
proteinuria (PU), arterial hypertension (AHT), and levels of serum
creatinine. FSGS/H was found in 103 bodies (86%) and was significantly
more frequent in Bertinis column (11.9%) than in the suprapapillary
cortex (7.5%): P < 0.001. For correlation with biological data a
repartition into three groups (G) according to the frequency of FSGS/H
in Bertinis column has been made: 01 with FSGS/H > 25%, 02 with
FSGS/H of 12 to 25%, and 03 with FSGS/H < 12%. Results are partly
summarized in the table below:
Proteinuria Average of
++ + (+) or — weight
G I 35% 55% 10% 134 g
G2 — 54% 42% 4% l4lgG3 — 17% 17% 66% l9Og
FSGS/H is most striking in a range of serum creatinine between Sand 10
mg% and more frequent in patients with AHT (140/90 mm Hg), but
independent of the level of AHT. We conclude that in AN the reduction
of kidney mass leads to the overload of remnant glomeruli inducing
proteinuria and FSG/H. AHT may favor glomerular damage.
Parathyroid hormone status and phosphate transport in proximal
brushborder membrane and whole kidney. J, Caverzasio and J. -P.
Bonjour. Pathophysio/ogisches Institut, Universitdt Bern, Bern, Swit-
zerland. Both the parathyroid hormone (PTH) and inorganic phosphate
(Pi) status influence the tubular Pi reabsorptive capacity, Dietary Pi
restriction affects the status of both, since it is accompanied by a rise in
calcemia and hence by an inhibition of PTH secretion. in the present
study we have assessed whether the change in the PTH status which
occurs during Pi restriction affects the response of the renal Pi transport
in the whole kidney and at the level of proximal brushborder membrane
vesicles (BBMV). Sham-operated (SHAM) and thyroparathyroidecto-
mized (TPTX) rats were switched from a normal (0.8%) to a low (0.2%)
phosphorus diet. The maximal tubular Pi reabsorption per milliliter of
glomerular filtrate (max TRPi/ml OF) in the whole kidney and the
initial (3.6 and 9 see) Natdependent Pi uptake by proximal BBMV
were determined before and after 1, 2, 3, and 8 days of Pi restriction.
Before Pi restriction max TRPi/ml OF was 1.94 0.04 and 4.03 + 0.14
jzmoles/ml GF in SHAM and TPTX rats, respectively. The correspond-
ing Na-dependent Pi uptake (3-sec value) was 137 23 in SHAM and
272 41 pmoles/mg protein in 1'PTX rats. During Pi restriction the
initial difference in max TRPi/ml OF remained constant throughout
the time course study. At 8 days max TRPi was in SHAM 3.08 0.09
and in TPTX 5.04 0.18 zmoIes/ml OF. In sharp contrast, at the
BBMV level the initial difference between SHAM and TPTX was
progressively reduced and became completely abolished 8 days after
starting the Pi restriction (SHAM = 425 69: TPTX 434 40
pmoles/mg protein). In conclusion, the overall tubular Pi transport
capacity and the Na-dependent Pi transport in the luminal membrane
of the proximal tubule appear to be affected quite differently by changes
in the PTH status during Pi restriction.
Aortic renin level in rats with varying plasma renin levels. A. E.c,sadki,
andJ. Atkinson. Inst/rut de Pharmacologic de l'Univerpité, Lausanne,
Switzerland. We have investigated the relationship between aortic renin
level (ARL) and plasma renin level (PRL) in male Wistar rats with
widely varying PRLs. Decreases in PRL were produced by 24-hr
unilateral or total nephrectomy; increases in PRL were produced by
clipping (ID 0.2 mm) of the left renal artery for 1-month. The latter
manipulation also induces arterial hypertension [systolic arterial pres-
sure (mm Hg) clipped rats 179 3 (N = 32), sham clipped controls 121
2 (N 10)]. Abdominal aorta fragments and blood samples were
taken under urethan anesthesia. Parallel groups were run for the
determination of renal cortex renin level (RCRL) as our method for
removal of the aorta blocks renal circulation. Plasma homogenates of
aorta or of renal cortex were incubated with excess rat renin substrate.
The angiotensin I generated was measured by radioimmunoassay, and
renin levels are expressed as ngAI mg (protein) hr l,
(Upped Ntphrt P444 ARt. I til I(ght (oottp
Ye, 2 Note — 'I '- .22 .40 II 44
Ye'. 7 lt 0 445 9 II 40 IN
Ye'. 'I Roth 11111 III)) 1141 III))
No 14 Note 4 11 1)4 1174 ' II 14
No 4 Roth I) II
Relov, he limit of tietesit,r for our
444 I)
'.tl), 444 ft
II
Abstracts 901
There was a statistically significant relationship between ARL and PRL
throughout all groups (ARL = 0.30 + 0.14.PRL, r = 0.64, P < 0.01).
We suggest that following clipping ARL increases in parallel with PRL
(and RCRL). Following removal of the clipped kidney (that is, removal
of the source of renin ?) ARL falls more slowly than PRL does
(compare group A with B or C).
Genetic study of PHA- and MLC responsiveness in the rat. D. Frei and
R. D. Guttman. Transplantation Service, Royal Victoria Hospital, and
McGill University, Montréal, Québec, Canada. In vitro responses to
mitogens and allogeneic antigens in mixed lymphocyte reactions repre-
sent two different proliferative responses. This study was undertaken to
determine whether the genetic control of these proliferative immune
responses was influenced by MHC or non-MHC genes. Previous
evidence has been obtained in several laboratories that the BN strain is
a low responder and the LEW strain a high responder in proliferative
reactions. Matings between these two strains to derive reciprocal
backcross and F2 hybrid lines were carried out and these populations
were tested in the following way: All animals were serotyped for MHC
antigens of the RT1 locus, and peripheral blood lymphocytes were
reacted against PHA and in mixed culture against LEW, BN, and LBN-
Fl hybrid strains. In addition, appropriate parental strain as well as F2
hybrid cardiac allografts were carried out and survival time monitored.
The data were the following: the PHA responses of the 17 LBN-F2
hybrids with the haplotype n/n showed a higher average stimulation
index (92.7 38.2 SE, range 0.9 to 606.7) than of the 41 LBN-F2 hybrids
with the haplotype 1/1 (28.9 6.0 SE, range 1.2 to 149.8), whereas the
MLC relative responses in both LBN-F2 hybrid groups were similar
(2.3 0.9 SE, range 0.2 to 15.9 in the n/n animals and 2.1 0.3 SE, range
0.1 to 8.8 in the 1/1 animals). The correlation between PHA and MLC
responses in both haplotypes of the LBN-F2 hybrids was not signifi-
cant. Allograft survival data showed two types of responses. Allografts
that were mismatched at the MHC were rejected rapidly and allografts
that were matched for the MHC had prolonged graft survival to some
extent. It is concluded that in vitro lymphocyte responsiveness to PHA
and to allogeneic cells in these rat strains is not linked to the RT1 locus
and that some other genetic determination than MHC occurs.
High diagnostic yield, but limited therapeutic benefit from aggressive
work-up in refractory hypertension. A. Gerber, P. Weidmann, and L.
Link. Medizinische Poliklinik, University of Bern, Bern, Switzerland.
An aggressive search for operatively remediable causes is generally
recommended for severe hypertension refractory to conventional treat-
ment with diuretics, betablockers and/or other sympatholytics, and
hydralazines or prazosin (RHT). However, the diagnostic yield and
therapeutic benefit from such an approach have not been assessed.
These aspects were evaluated in 32 patients with severe RHT, a mean
age of 54 years, and mean serum creatinine of 1.5 mg/dl (range, 0.8 to
6.3). Renal angiography was performed in all patients, intravenous
pyelography (IVP) in 30, measurements of catecholamines and/or their
metabolites in 31, and renal vein renin studies in 23. Renal lesions were
found in 23 patients (72%). Fifteen (47%) had renal artery stenosis
(RAS), seven unilateral, seven bilateral, one postrenal transplant, three
of them in association with pyelonephritis; a state postrenal infarction,
nephrosclerosis, pyelonephritis, interstitial nephritis or nephrolithiasis
were diagnosed in 8 patients. IVP was false negative in seven out of 15
patients with RAS. However, the renin test was consistent with renal
ischemia in all patients with RAS, except in the one with a renal
transplant, and it was negative in seven of eight without RAS. No case
of previously undiagnosed pheochromocytoma was encountered. Oper-
ative treatment with transfemoral endoluminal dilatation or surgery
appeared justified in 11 patients with RAS; hypertension was cured in
one only; five required continued conventional drug therapy; and five
the addition of new potent agents such as minoxidil, carpracidil or
captopril. The potent drugs also were necessary in the four non-
operable patients with RAS and in 14 of 17 without RAS. After a mean
follow-up of 30 months, blood pressure control was satisfactory and not
different between patients with operated RAS, non-operated RAS or
without RAS. This suggests that in RHT the incidence of false negative
IVP's for RAS may be considerable. Nevertheless, a more aggressive
work-up provides a high diagnostic yield but rather limited therapeutic
benefit. A primary therapeutic approach with potent drugs may often
reduce the need for extensive diagnostic procedures in RHT.
Manganese prevents the hypoxemia-induced renal vasoconstriction.
J.-P. Guignard and C. Wallimann. Service de Pédiatrie, CHUV,
Lausanne, Switzerland. In the rabbit acute normocapnic hypoxemia
increases renal vascular resistance, leading to renal hypoperfusion and
decreased glomerular filtration rate (GFR), water, and electrolyte
excretion. This response is associated with increased plasma renin
activity; it is prevented by verapamil, a potent inhibitor of transcellular
calcium ion transport. The renal pathophysiology of hypoxemia was
further defined in studies using managanese as an inhibitor of transcel-
lular calcium ion transport. Experiments were performed in nine
mechanically-ventilated rabbits. Inulin and PAH were used as markers
of GFR and renal plasma flow, respectively. The left renal artery was
catheterized and infused with sodium chloride during the control
period, and with manganese chloride, 5.5 x iO M/kg x mm, during
hypoxemia. Each kidney served as its own control. Acute hypoxemia
(PaO2 = 36 mm Hg) did not change mean systemic blood pressure
which remained above 100 mm Hg. In the right kidney, acute hypoxe-
mia increased renal vascular resistance from 12.5 to 32.7 mm Hg/mI/kg
X mm, and decreased urine flow to 58%, GFR to 61%, RPF to 68%, and
Na fractional excretion to 77% of the control values. Intrarenal arterial
infusion of manganese, an antagonist of calcium entry into the cells,
abolished the effect of hypoxemia in the left-infused kidney. Renal
vascular resistance did not increase and remained below 16.8mm Hg/kg
X mm, urine flow remained at 101%, GFR at 83%, RPF at 101%, and
Na fractional excretion at 113% of the control values. Potassium
excretion increased to 136% above its control level. These results show
that the hypoxemia-induced renal vasoconstriction can be prevented by
inhibiting transcellular calcium ion transport and suggest that this
vasoconstriction is mediated by angiotensin II, for the expression of
which calcium ion is an important cofactor.
CGS 13945: A new angiotensin converting enzyme inhibitor in normal
volunteers. B. Jacot des Combes, G. A. Turini, H. R. Brunner, M.
Porchet, D. S. Chen, and S. Ben Sen. Centre Hospitalier Universitaire,
Lausanne, Switzerland, and Ciba-Geigy Corporation, Summit, New
Jersey. CGS 13945, 1-(4-Ethoxycarbonyl-2,4(R,R)-dimethylbutanoyl)-
indoline-2(s)-carboxylic acid, was evaluated in 14 male volunteers.
First, the capacity of a single oral dose (from 10 to 500 mg) to inhibit the
pressor response to exogenous angiotensin I (ANGI) was tested with
blood pressure and heart rate monitored continuously through an intra-
arterial catheter. The 250 and particularly the 500 mg dose markedly
reduced the pressor response to ANGI within 0.5 hr and for a period
exceeding 4 hr. There was a close correlation between the pressor
response to ANGI and plasma converting enzyme activity (CEA). In a
second part, plasma renin activity (PRA), CEA, ANGI, angiotensin II
(ANGII), and plasma aldosterone (Aldo) were measured serially before
and up to 48 hr after either 250 or 500 mg p.o. of CGS 13945 to six
volunteers each. PRA and Al rose, while CEA, All, and Aldo fell.
Twenty-four hours following the administration of 500 mg of CGS
13945, CEA was still significantly decreased. No side effects were
observed. It is concluded that CGS 13945 is an orally effective, non-
thiol, angiotensin converting enzyme inhibitor with long duration of
action.
Developments in the medical treatment of idiopathic urolithiasis. P.
Jaeger, L. Portmann, A. F. Jacquet, andP. Burckhardt. Department of
Medicine, University Hospital, Lausanne, Switzerland. The authors
raised four questions dealing with the medical treatment of idiopathic
urolithiasis. (1) Is it rational to advise idiopathic stone formers (1SF) to
drink water with low Ca content? Four Ca-hyperabsorbers were asked
to drink, first tap water ad lib, then successively 2 liters/day of tap
water, of a low Ca (A) and of a Ca-rich (B) water. On A, subjects were
normocalciuric but hyperoxaluric whereas on B they were hypercal-
ciuric but normooxaluric. Ca• Ox concentration product and CaJMg
concentration ratio were slightly higher on B than on A, but even on B
both parameters were significantly lower than on tap water ad lib. (2)
Can the mild hyperoxaluria of some 1SF be lowered? Isolated mild
hyperoxaluna has been found in 6% of our population of 1SF. Five of
these patients received pyridoxine (300 mg/day orally for 2 months, and
UOx V was measured before, during, and after treatment. In all
patients pyridoxine led in 15 days to normalization of UOx V which
stayed within the normal range in a follow-up period of 8 months after
the interruption of treatment. (3) What is the optimal dosage of
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chlorthalidone (Ct) as an anticalciuric agent? Six patients with idiopath-
ic hypercalciuria (IHC) received Ct at three different dosages (25, 50,
and 100 mg/day prescribed for 2 months each. Plasma urate, urine pH,
and uricosuria increased in a dose-dependent manner and so decreased
plasma K and calciuria. However, increasing Ct from 50 to 100 mg/day
did not further depress calciuria, whereas it did accentuate the hypoka-
lemia as well as elevate uricemia, uricosuria and UpH. (4) Do diuretics
other than thiazides have an anticalciuric effect? Ten IHC-patients
received 100 mg/day either of spironolactone (Sp) or of Ct. After 1
month on treatment calciuria decreased by 38% (P<0.Ol) in the Ct-
group and by 20% (P<0.05) in the Sp-group. However, whereas on Ct,
plasma K decreased (P<0.0025), and plasma urate (P<0.0005,t, urico-
suria (P<0.05) and UpH (P<0.025) increased. On Sp no change or even
a slight decrease (uricosuria P<0.05) in these parameters occurred.
Conclusions are: In the prevention of the recurrence of nephrolithiasis
(1) the advice to have a high fluid intake is probably more relevant than
that to select a water with particularly low Ca content; (2) in idiopathic
hyperoxaluria, short-term pyridoxine is effective in lowering oxalate
excretion and the benefit seems to be sustained for many months after
the interruption of treatment; (3) the anticalciuric effect of Ct appears
dose-dependent and the 50mg daily dose looks optimal for IHC; (4) the
unspecific anticalciuric effect (via hypovolemia) of Sp might be of
therapeutic interest since the drug does not have an unfavorable effect
on K, urate, or UpH.
Calcium, calcium regulating hormones, and renal compensatory hyper-
trophy. J. Jobin, J. Caverzasio, C. Taylor, A. Mba kop, F. Chatelanat,
and f-P. Bonjour. Pathophysiologisches Inslitut, Universitdt Bern,
Bern, and Departement de Pathologic, Universitd de Genève, Gendve,
Switzerland. The influence of calcium (Ca) supply, parathyroid hor-
mone (PTH), calcitonin (CT), and 1,25-dihydroxyvitamin D3
[l,25(OH)2D] on renal compensatory hypertrophy (RCH) has been
studied in unilaterally nephrectomized (UNI-NX) rats. UNI-NX rats
were pair-fed diets with high (1.1%, HCaD) or low (0.1%, LCaD) Ca
content for 3, 8, and 15 days. After UNI-NX the wet weight of the
remaining kidneys increased much more in rats fed LCaD than HCaD.
The increased wet weight of the remaining kidney under LCaD was
associated with a highly significant augmentation in dry weight, total
protein and DNA content. LCaD did not display such effects in sham-
operated rats with intact renal mass. The amount of dietary Ca did not
influence the progressive rise in GFR (clearance of inulin) of the
remaining kidneys as assessed 3, 7, and 14 days after UNI-NX.
Microscopic examination (hemotoxylin-eosin and Van Kossa stainings)
did not reveal any difference between remaining kidneys of UNI-NX
rats fed LCaD and HCaD. The surface density of glomeruli tended to be
lower in the remaining kidneys of UNI-NX rats fed LCaD as compared
to HCaD, a finding consistent with a further and predominant increase
in the tubular mass. In UNI-NX rats fed LCaD chronic administration
of CT in doses which induced hypocalcemia did not inhibit the
enhanced RCH induced by LCaD. In UNI-NX rats fed HCaD chronic
administration of PTH mimicked the effect of LCaD. An increased
RCH was also observed in IJNI-NX rats fed HCaD and chronically
treated with l,25(OH)2D3. In conclusion, dietary Ca restriction can
enhance markedly the compensatory but not the normal growth of the
kidney. The data suggest that among the Ca regulating hormones, PTH
and maybe I ,25(OH)2D3 could be involved in the stimulating action of
Ca restriction on RCH.
Development of the metanephros in an allogenic graft. J. Kazimierc-
zak. Instilut d'Hislologie Ct d'Emhryologie, CHUV, Lausanne, Swit-
zerland. The development of mouse metanephros in an allograft was
studied with transmission and scanning electron microscopy (EM). The
kidney of a 13-day-old mouse fetus consists mainly of the metanephric
blastema cells occasionally aggregated in the form of caps around the
terminal dilatations of the branches of the uretheric bud. Such kidneys
of NMRI mouse fetuses were grafted under the renal capsule of adult
mice of the same strain, and 1 and 2 weeks later they were processed for
EM. it was observed that in a 1-week-old graft the induction processes
persisted and new generations of nephrons were developing; in two-
week-old grafts the nephronogenesis had already terminated and only
the nephrons in advanced stages of differentiation were present. The
vasculature of the graft was restored in continuation with the renal
vessels of the recipient, and the development of the kidney continued in
the whole as in the nephron itself. In the glomerulus the fenestration of
the endothelium and the food processes of the podocytes were well
developed and all the glomerular structures were in identical rapport to
those of the host. The tubular part of the nephron was generally less
differentiated than the glomerulus; nevertheless, the proximal tubules
had developed the brush border and some basal infoldings, and the
tubular cells were presumably capable of some transport performances,
since the peroxidase injected into the host's circulation was detected
with a histochemical method in the apical vesicles and vacuoles of the
proximal tubule of the graft. Furthermore, the juxtaglomerular epitheli-
oid cells with granules were also present in the graft, as well as large
cysts lined by an apparent transitional epithelium. The latter could be
taken possibly as an indication of urine formation in the graft. However,
in some 2-week-old grafts the infiltration of lymphocytes, plasmocytes,
and mastocytes was observed together with certain signs of tubular and
glomerular involusions suggesting the phenomenon of rejection in the
corresponding grafts.
Effect of the converting enzyme inhibitor (CEI) MK 421 on ischemic
acute renal failure (ARF) in the rat. A. M. Koelz, F. P. Brunner, P.
Wunderlich, and G. T. Thiel. Departments of Internal Medicine and
Research, University of Base!, Base!, Switzerland. Tubuloglomerular
feedback (TGF) mediated by local generation of renin and angiotensin
may be of importance in aggravating ARF. Therefore, we inhibited the
renin-angiotensin system (RAS) in salt-depleted rats with the CE! MK
421 5 mg/kg p.o. 8-hr (acute) or 150 mg/liter drinking water for 14 days
(chronic). TGF was measured as proximal tubular pressure (PTP) at
perfusion rates 0 to 40 nI/mm of Ringer's solution. SFP fell by 28 3%
in controls, 4.5% in acutely and 8.2% in chronically treated animals.
ARF was then induced in previously uninephrectomized rats with 70
mm left renal artery occlusion (RAO). At 4 to 6 hr the values for
untreated and treated groups were: BP 115 28 and 101 20 mm Hg;
renal blood flow (RBF) 2.9 1.8 and 3.4 1.6 mI/mm x 100 g; GFR
0.011 0.016 and 0.019 0.029 mI/mm x lOt) g. At 24 hr BP was 128
2landlO7±2OmmHg;RBF3.8±l.land4.l±l.lml/minxlOOg;
GFR 0.019 0.032 and 0.006 0.006 mI/nun x 100 g. Chronic
treatment did not significantly alter these results. After sham operation
BP was 129 9 and 87 14mm Hg; RBF 5.9 1.3 and 4.4 1.3 ml/
mm x 100 g, GFR 0.557 0.016 and 0.304 0.051 mI/mm x 100g. In
conclusion MK inhibited TGF significantly, but it failed to ameliorate
renal function after 70 mm RAO.
Serial measurements of circulating immune complexes before and after
renal transplantation. G. Keusch, H. M. Vonwiller, A. von Felten, H. R.
Burger, and U. Binswanger. Departement für Innere Medizin und
Institut für Pathologic, Universitatsspital Zurich, Zurich, Switzerland.
The role of circulating immune complexes (CIC) in renal transplantation
(RT) is still controversial. We therefore analyzed CIC before and after
RT (during the first two post-transplant months every 2 weeks and later
in monthly intervals up to 1 year after RT) in a prospective study of 141
consecutive patients. CIC were measured using the Raji cell assay as
originally described by Theofilopulos and Dixon. The amount of CIC
was expressed as micrograms of heat aggregated human IgG equivalent
per milliliter of serum. The upper limit of normal sera was 25 rg/ml. The
values are expressed as geometric means (—1 SD/+ I su). In 97 of 133
rejection episodes (RE) a renal biopsy was performed and the histopath-
ologic changes were semiquantitatively assessed and classified in a
cellular or vascular type of rejection. The results were: Before trans-
plantation CIC were detected in 104 of 141 patients (73.8%), and the
mean value was 135.9 (55.2/335.9) sg/ml. The level of CIC was
positively correlated with the number of grafts (P < 0.01) and the
occurrence of chronic active hepatitis (P < 0.01). No correlation was
found between CIC and the underlying kidney disease, the number of
blood transfusions prior to TPL, and the pre-existing HLA-antibodies.
Graft survival and the number of RE was not influenced by the level of
CIC prior to RT. In patients with a graft survival ll months the
average and peak post-transplant CIC levels were significantly higher as
compared to patients with a graft survival of 12 months: 64.4 (21.8/
191.0); 87.7 (26.0/295.8) versus 39.6 (18.4/85.3); 56.8 (21.0/150.1) .tg/ml;
P < 0.01. There was a positive correlation between CIC and serum
creatinine in the post-transplant period (P < 0.001). The histopathologic
severity and type of RE did not correlate with CIC. In patients without
RE CIC were significantly lower: 41.2 (39.6/42.9) as compared to
patients with RE: 61.8 (56.2/68.0); P < 0.05. In conclusion, the
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preoperative CIC level showed no influence of graft survival. No
correlation between severity and type of RE and level of CIC was
found. Patients with elevated CIC in the post-transplant period had a
significantly lower graft survival.
Segmental distribution of fat deposits in the nephron of starved rodents.
M. Le Hir and U. C. Dubach. Medizinische Universitãts-Poliklinik,
Basel, Switzerland. The concentrations of triglycerides in the kidney is
proportional to the concentration of fatty acids in serum. It has not yet
been shown which segments of the nephron accumulate fat in situations
of increased levels of fatty acids in serum (for example, starvation and
diabetes). We stained fat deposits with Sudan black in cryostat sections
of kidneys of rat, rabbit, and guinea pig. Fat droplets could not be
detected in the kidneys of animals fed ad libitum. During starvation (48
hr) fat accumulated mainly in the proximal tubule. However, the first
half of the proximal convolution remains nearly free of fat. Besides the
proximal tubule, the medullary part of the thick ascending limb only
accumulates great quantities of fat droplets in rabbit and guinea pig but
not in rat. The cortical collecting duct shows fat deposits in guinea pig,
only. Because the distribution of fat deposits does not seem to correlate
with the capacity of the different segments to oxidize fatty acids, the
patterns observed may be explained rather by segmental differences
either in the uptake of fatty acids or in the capacity for synthesis of
triglycerides.
Heal calcium and phosphate secretion in vitamin D-depleted and uremic
rats. J. Peters, H. Weiser, W. Meier, and U. Binswanger. Nephrolo-
gische Station, Departement für Innere Medizin, Universität Zurich
und F. Hoffmann-La-Roche, Base!, Switzerland. Unidirectional ileal
calcium and phosphate transport in rats was elevated in vitro by means
of the modified Ussing technique. Groups of rats included vitamin D-
depleted (1), five-sixths nephrectomized (2) and control (3) animals.
Results are as follows: (nmoles/cm2/ms; means SD):
JSM JMS 'Net
I Ca 45.21 4.35" 21.55 4.82 —23.66 3.53"
P 84.52 l1.52b 38.48 16.75 —46.04 18.Sla
2 Ca 37.12 4.69a 23.79 6.76 —13.33 6.58a
P 62.69 10.84' 22.62 10.16 —40.01 12.OOa
3 Ca 50.63 6.20 24.20 7.87 —26.43 2.83
P 87.37 9.84 16.58 3.58 —70.79 12.16
The significance of l vs. 3 and 2 vs. 3 was: a P < 0.005; b NS.
Unidirectional ileal calcium and phosphate secretion is impaired in
uremia but not by vitamin D depletion alone. Short-time 1 ,25(OH)2D3
treatment was able to restore the defect to values observed in control
animals. Net ileal secretion for calcium is changed according to
unidirectional flux, whereas net phosphate secretion is decreased to the
same extent by vitamin D depletion as well as by uremia. In addition to
the kidney, ileal phosphate secretion represents a second site of
phosphate removal from the body.
Complications of continuous ambulatory peritoneal dialysis requiring
surgery. M. Rastorfer, A. Medina, and K. Zaruba. Nierenstation und
Chirurgische Klinik Stadtspital Waid Zurich, Zurich, Switzerland.
Considering the growing importance of continuous ambulatory perito-
neal dialysis (CAPD), awareness of possible complications related to
this method is essential. Conditions requiring surgical intervention
thereby take a special position. From April 1979 to October 1982 a total
of 37 patients (21 men and 16 women, mean age 58 years) were treated
in our CAPD program. During this period, 21 operations were neces-
sary due to various complications as stated below: (1) Hernias: In five
patients (13.5%) three incisional and two incarcerated inguinal hernias
were repaired surgically. Four other hernia patients were meanwhile
treated conservatively using an elastic abdominal bandage. (2) Peritoni-
tis: The peritoneal catheter was removed because of peritonitis in six
patients (16.2%): four patients with mycotic peritonitis, one patient with
resistant bacterial peritonitis and one patient with bowel perforation in
diverticulitis. (3) Catheter tunnel infection was seen in five patients
(13.5%). The removal of the catheters in four patients and incision in
one patient were needed for this reason. (4) Other catheter related
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problems: The catheter had to be replaced in five patients (13.5%):
twice because of catheter tip displacement, twice for catheter obstruc-
tion and once because of dialysate leakage. Only in two of these 21
patients CAPD had to be discontinued, and the patients were trans-
ferred to hemodialysis. Six other patients changed to hemodialysis
because of preference.
Treatment of peritonitis in patients undergoing chronic ambulatory
peritoneal dialysis (CAPD): Efficacy and pharmacokinetics of Cefopera-
zone (Cefobis®). A. Seiler, B. Frey, M. Rudhardt, and J. Hod/er.
Medizinische Poliklinik, Inseispital, Bern, and Policlinique Médicale,
Hôpital Cantonal, Geneva, Switzerland. The treatment of 21 consecu-
tive episodes of acute peritonitis in 16 hospitalized CAPD-patients with
normal hepatic function by Cefoperazone alone resulted in complete
healing of 12 episodes within 7 days. Three further episodes healed after
3 weeks. In 6 episodes, Cefoperazone had to be replaced by other
therapeutic means. The treatment schedule consisted of intravenous
infusion of 2 g Cefoperazone in the first 6 hr. Simultaneously, acute
peritoneal dialysis (PD), adding 0.1 g of Cefoperazone per liter to each
dialysis bag, was installed for 48 hr. Thereafter, PD was switched to
CAPD (6 bags p.d.), each bag containing 500 mg of Cefoperazone. The
pharmacokinetics of Cefoperazone after i.p. and/or i.v. application
were studied in nine CAPD patients without peritonitis. The analysis of
the time course of plasma and dialysate Cefoperazone concentrations
after intravenous injection and intraperitoneal instillation of 1 g Cefo-
perazone on different days in three patients yielded values (means
5EM) of 3.05 0.7 hr for plasma halftime, 82.3 (33 to 164) ml min' for
total and 3.8 (1.95 to 5.2) ml mm ' for peritoneal clearance. The
percental resorption of 1 g of Cefoperazone instilled in 2 liters of
dialysate fluid was calculated to be 60.7 7.4% after 6 hr. Maximal
mean blood levels of 14.9 2.0 sg/ml were reached 2 hr after the
instillation of the dialysate fluid into six patients. The application of 2 g
of Cefoperazone, divided in two of four CAPD bags p.d. on 2 consecu-
tive days, did not result in cumulation of the drug during day 2. Finally,
in vitro studies of the growth inhibitory and bactericidal effects of
Cefoperazone against the ATCC strains Staphylococcus aureus 25923,
Staphylococcus epidermidis 14900, Escherichia co/i 25922, and Klebsi-
ella pneumoniae 27736 in the CAPD solution lead to the result, that
Cefoperazone, as well as Cefomandol and Cefotaxim, displays similar
antibacterial efficacity to the aminoglycoside, Gentamycin, if the dialy-
sate fluid contains 1% albumin. However, only Gentamycin was
effective against ATCC strain 27853, Pseudomonas aeruginosa.
Transport of '4C-salicylate by the isolated and perfused proximal
tubule (S2 segment) of the rabbit kidney. L. Schild and F. Roch-Ramel.
Institut de Pharmacologie de 1' Université, Lausanne, Switzerland. We
studied the transport characteristics of the secretory and the reabsorp-
tive fluxes of The secretion of '4C-salicylate was satura-
ble, the apparent Km was 66 M and the Vmax 2500 fmolesmin 1mm'
tubular length. It was inhibited by organic anions such as probenecid,
para-aminohippurate, and pyrazinoate (l0 M). The secretion was not
influenced by the pH of the bath and was not inhibited by an inhibitor of
carbonic anhydrase (ethoxyzolamide i0 M). '4C-salicylate reabsorp-
tion was studied when the pH of the perfusate was either 7.4 or 7.0 ('4C-
salicylate concentration was iO M). The pH of the perfusate was
maintained at pH 7.0, either by adding an impermeant buffer (HEPES
20 mM) in the perfusate or by increasing the Pco2 in the bath and
consequently in the perfusate.
pH of
perfusate
Pco2 in bath
mm Hg
Reabsorptive flux
fmo/es,ninmm' N
7.4 25 to 37 122 12 10
7.0 65 to 85 466 28 6
7.0 25to37 68±23 6
The reabsorption of '4C-salicylate (control conditions: pH 7.4 and Pco2
25 to 37) was inhibited by 96% when ethoxyzolamide l0 M was added
to the bath and by 100% when bicarbonate (15 mM) was added to the
perfusate. These data suggest that the reabsorption of salicylate is
coupled to H secretion (increased salicylate reabsorption and H
secretion at high Pco2; decreased H' secretion and salicylate reabsorp-
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tion under carbonic anhydrase inhibition). OH— ions generated in the
cell by H6 secretion might exchange with the luminal salicylate.
Inhibition of salicylate reabsorption by bicarbonate might be explained
by a competition for this anion exchange transport.
Observation of papillary necrosis by sonography in a renal allograft. J.
Tuma, M. Bfirgin, L. Matter, F. W. Reutter. Kantonsspital St, Gallen,
St. Gallen, Switzerland. Papillary necrosis is a very rare finding in
kidney allografts. To our knowledge only 17 cases have been recog-
nized, either by pyelography, passage of necrotic papillary material in
the urine or by autopsy. We observed a 22-year-old woman, transplant-
ed in 1976 because of traumatic infarction of her unique kidney. Until
1980, even under several episodes of urinary tract infection and viral
diseases (cytomegalovirus, polyomavirus, herpes simplex, and herpes
zoster), kidney function was stable with a serum creatinine of 130 to 170
.tmole/Iiter. Significant proteinuria and hematuria as well as arterial
hypertension (AHT) were absent. In month seven of pregnancy (Janu-
ary 1981) she was affected by mononucleosis and had proteinuria (2 to 3
g124 hr), microhematuria and mild AHT, which persisted ever since.
Sonography before delivery revealed only mild renal pelvis dilatation.
One year later necrosis and calcification of almost all papillas was
detected sonographically. Renal function slightly decreased 3 months
after delivery. A transplant biopsy 6 years after transplantation showed
fibrous endarteriitis, microangiopathic glomerular lesions, and tubu-
lointerstitial fibroedema with mononuclear infiltrates. Conditions favor-
ing papillary necrosis as diabetes mellitus, urinary tract obstruction,
vesicoureteral refiux, analgesic abuse or sickle cell hemoglobinopathy
could be excluded. Renal histologic changes may be explained by
chronic rejection but papillary lesions remain obscure. Virus diseases
and urinary tract infections have to be considered.
Factors limiting the hypotensive effect of prazosin in awake rats. B.
Waeber and H. R. Brunner. Département de Médecine, CHUV,
Lausanne, Switzerland. The role of the autonomic system, angiotensin
II and vasopressin in limiting the hypotensive effect of prazosin, 0.25
mg iv., was investigated in conscious normotensive rats. Within 45
mm, mean blood pressure fell from 120 I to 98 1 mm Hg (mean
SEM, P < 0.001) while pulse rate rose from 463 9 to 500 9 b/mm (P
<.0.01). Plasma norepinephrine and epinephrine levels were higher in
prazosin-treated rats (PR) than in the controls (CR) (P < 0.001). In the
PR, plasma renin activity was 4x (P < 0.001) and plasma vasopressin
7x (P < 0.01) higher than in the CR. Blockade of angiotensin II with
saralasin (10 g/min) further decreased blood pressure of the PR by 22
4 mm Hg (P < 0.001). In contrast, dPVDAVP (25 sg), a vasopressin
antagonist, had no effect. Prazosin decreased the pressor response to
methoxamine (10 g) by 80% (P < 0.001) but not to angiotensin 11(60
ng). However, prazosin enhanced the reflex bradycardia induced by
angiotensin II (P < 0.001). These data demonstrate that both the
sympathetic and the renin angiotensin system are markedly stimulated
by prazosin which limits its hypotensive action. In contrast, although
plasma vasopressin is also increased, its pressor action is effectively
buffered, probably due to enhanced baroreflex sensitivity.
Hemodiafiltration: The step toward shorter dialysis treatment times. J.
P. Wauters, M. Meuwly, and C. Widmer. Division de Nephrologie,
Département de Médecine, Hôpital Universitaire, Lausanne, Switzer-
land. Hemodiafiltration (HDF), that is, the simultaneous application of
hemodialysis and hemofiltration, has been proposed mainly to combine
the high clearances of hemodialysis for small molecules and hemofiltra-
tion for larger ones. For 1 year we have applied HDF using the A 2008 C
monitor and Hemoflow D6 filter. Dialysate flow was at 500 mI/mm.
Blood flow was usually at 280 mI/mm. Substitution fluid (4.5 liters per
session) consisted of: Na 135, K 2, Ca 3.75, Mg 1.5, Cl 108.5, lactate
33.75 mEq/liter. At blood flows of 200 and 300 mI/mm, respectively, the
clearances measured in vivo and corrected for ultrafiltration were at 182
23 and 249 4! mI/mm for urea, 162 18 and 219 34 mI/mm for
creatinine, and 175 14 and 233 13 mI/mm for phosphate (mean 1
SD). In three patients treated successively with hemodialysis (HD) for
over 1 year, hemofiltration (HF) for 1 year, and hemodiafiltration
(HDF) for 4 months, the mean results obtained during the last 3
consecutive months were:
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BP ry,lol± (28 II 135 8
dir slolr, prior Ho 75 7 76 9 IpIlrrpp 32 3 13 3
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The clinical tolerance of HDF was good or excellent in over 95% of the
sessions. Fluid removal exceeding 4 liters per session needed resetting
of the treatment program. The cost of the disposables in the three
different treatment modalities was 68 Sfr. for HD, 262.60 for HF and
131.40 for HDF, without re-use of the filter which was technically easy.
In conclusion, hemodiafiltration allows a one-third reduction in treat-
ment time when compared to hemodialysis with a better clinical
tolerance and an effective removal of measurable uremic toxins. Cost,
closer monitor supervision by the staff, and difficulty in the treatment of
hyperhydration states are the present disadvantages of the system.
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